Resonance Health Limited announced that it has appointed Ms. Liesl Ellies as Joint Company Secretary, effective immediately. Following Ms. Ellies' appointment, Ms. Ellies, Mr. Nicholas Allan, and Mr. Mitchell Wells will be joint Company Secretaries and will share responsibility for communications with ASX in relation to Listing Rule matters under ASX Listing Rule 12.6.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | +1.56% | +4.84% | +8.33% |
05-31 | Resonance Health Acquires TrialsWest | MT |
05-31 | Resonance Health Limited completed the acquisition of TrialsWest Pty Ltd from Helen Pavitt, Michelle Davies, and Peter Bremner. | CI |
1st Jan change | Capi. | |
---|---|---|
+8.33% | 19.01M | |
+8.38% | 217B | |
+15.78% | 195B | |
+31.27% | 112B | |
+3.76% | 65.83B | |
+14.19% | 52.67B | |
+4.70% | 49.86B | |
-3.93% | 38.18B | |
-0.47% | 35.39B | |
+23.96% | 31.02B |
- Stock Market
- Equities
- RHT Stock
- News Resonance Health Limited
- Resonance Health Limited Appoints Liesl Ellies as Joint Company Secretary